{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAkJSx6-EJDA","lastupdate":"2022-02-28T00:00:00.000Z","update_date":"2022-02-28T00:00:00.000Z","lastModified":"Mar 16, 2025","active":1,"confidence_score":83,"confidence_score_reason":"homepage, video or image, news, markets, external profiles, not claimed","urlname":"immunorizon","minimal_profile":null,"status":"Acquired","fullstatus":"Acquired by Purple Biotech on Feb, 2023","acquired":1,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$ssQcjPiSvqcUmSFyHChKIXzGUZooTfyoYf4viTyllGpoYwnGo5WQhq","name":"Immunorizon","oneliner":"T-and NK-cell Engagers for Cancer Therapy","registrar":"515756047","website":"","careerspage":"","founded_month":12,"founded_year":2017,"formernames":["ExploreBio1"],"sociallinks":{"twitter":"","youtube":"","facebook":"","linkedin":"","instagram":""},"social":[],"flattenedsociallinks":null,"apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":null,"employees":"1-10","employees_exact":2,"patent":0,"raised":0,"stage":"Acquired","public_stage":"Acquired","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":[""],"about":"Immunorizon is developing conditionally activated tumor-restricted T- and NK-cell engagers for cancer therapy. The company extends its pipeline and uses tri-specific constructs with additional tumor-associated antigens and diverse engagers with both T-cells and NK-cells.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"","country":null,"address":{"israeli":[{"id":"6929a06d-2273-4afb-ad3b-0ba00acd5c44","city":"Yavne","type":null,"address":"Yavne, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":"Center District","news":[],"newsNumber":0,"techcommunityinvolvement":null,"mediagallery":[],"tags":["cancer-therapy","immunology","oncology","antibodies","biotechnology"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7vMIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B"],"productstage":"Clinical Trial","products":[],"geomarkets":[],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":2,"lastfunding":"Undisclosed","totalrounds":3,"fundingstage":"Acquired","totalfunding":"Undisclosed","publicinvestors":2,"lastpublicfunding":0,"totalpublicrounds":3,"totalpublicfunding":0},"team":[{"name":"Oren Bogin","email":"orenbogin@gmail.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAkJSGgocLDA","bounced":false,"claimed":0,"founder":0,"urlname":"oren-bogin","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICQxNHx9AsM","position":"CEO","last_name":"Bogin","claimtoken":"2d3b7ab9a557c005eae25800420a5bbfc35a0ea66fc6e80289715d97d4181156","first_name":"Oren","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/orenbogin/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-02-28 15:19:01.000000","initials":"OB","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Liat Dassa","email":"","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAkKTgzO0IDA","bounced":false,"claimed":0,"founder":0,"urlname":"liat-dassa","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICQtObQlwgM","position":"VP R&D","last_name":"Dassa","claimtoken":"21206d3ee698b04f9df1d9043788658ca74729e70d93a5c08dff68c0b62d2681","first_name":"Liat","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/liat-dassa-321b75ba/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":null,"initials":"LD","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Pharmaceuticals","sectorverify":null,"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoNqyo8cLDA","fullname":"Yotam Maman"},"biverifydate":"2022-03-01T00:00:00.000Z","crunchbaseid":"","lastupdator":"Maor Perlov","lastupdator_email":"maorperlov@gmail.com","creator":"Maor Perlov","creator_email":"maorperlov@gmail.com","createdate":"2022-02-28T00:00:00.000Z","biverification":"Yotam Maman","sectorverification":null,"affiliatedOrganizations":null,"timeline":[{"id":"ZRQcERKz5pC08ibM3xtBBN3Jxs6tpU6MWyYrn3y206erEu5b4ljakV","date":"Feb 2023","amount":"$100M","source":"https://www.fiercebiotech.com/biotech/purple-biotech-paint-immunorizons-tri-specific-antibodies-100m-acquisition","mnatype":"Acquisition","eventtype":"MNAEvent","investment":[],"wasacquired":1,"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"acquiredcompany_mna":"Purple Biotech","acquiredcompany_mna_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6HiewIDA","acquiredcompany_mna_type":"Startup","acquiredcompany_mna_hidden":false,"acquiredcompany_mna_fullurl":"/company_page/kitov-pharmaceuticals","acquiredcompany_mna_logokey":"$25bRhdsVgwjsw5gGHwllY1Bhuh47gHfhNqXV6cabjGJHh5Ao4rQ1Dw","acquiredcompany_mna_urlname":"/company_page/kitov-pharmaceuticals","acquiredcompany_mna_homepage":"https://purple-biotech.com/","style":"","hiddenCompanyTooltip":"","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$25bRhdsVgwjsw5gGHwllY1Bhuh47gHfhNqXV6cabjGJHh5Ao4rQ1Dw","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","exit_label":"EXIT","po_label":"Initial Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":100000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"ISiyLn6zvM4pQ7W2pqGZxMzy69eMtrdLg2JlT7voCgiHLQghhxiCnO","date":"Feb 2020","amount":"Undisclosed","source":"m ventures","eventtype":"FundingRoundEvent","investment":[{"name":"M Ventures","type":"Investor","amount":null,"hidden":false,"country":"Netherlands","fullurl":"/investor_page/ms-ventures-israel-bioincubator","logokey":"$T9rrER6ccOAeHaUhrRclT8sLHnVVdbnxSAW33L0YVjduN9k2EI95Nh","tagline":null,"urlname":"/investor_page/ms-ventures-israel-bioincubator","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgL-llZsJDA","fundingtype":"Corporate VC","leadpartner":null,"investmentid":"4OAMXA0VJCdQwPTAAd930bKbC66sl1kynfu9QqWfPOIaI1fmBghQP7","fundingsubtype":"Corporate VC","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$T9rrER6ccOAeHaUhrRclT8sLHnVVdbnxSAW33L0YVjduN9k2EI95Nh","leadcaption":"","followupcaption":"Follow on "}],"eventvisibility":"Public","amountvisibility":null,"fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"CZDX5geGEMqhQjepWeHStWti2BKFDicKaq6FvOVLivMVnBbO8V7jqr","date":"Apr 2019","amount":"Undisclosed","source":"m ventures","eventtype":"FundingRoundEvent","investment":[{"name":"M Ventures","type":"Investor","amount":null,"hidden":false,"country":"Netherlands","fullurl":"/investor_page/ms-ventures-israel-bioincubator","logokey":"$T9rrER6ccOAeHaUhrRclT8sLHnVVdbnxSAW33L0YVjduN9k2EI95Nh","tagline":null,"urlname":"/investor_page/ms-ventures-israel-bioincubator","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgL-llZsJDA","fundingtype":"Corporate VC","leadpartner":null,"investmentid":"TbVtBlb53asL6frW31uPYgHRVM08OjvXEtnPBthvVTiAVZXM7Tcc8r","fundingsubtype":"Corporate VC","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$T9rrER6ccOAeHaUhrRclT8sLHnVVdbnxSAW33L0YVjduN9k2EI95Nh","leadcaption":"","followupcaption":"Follow on "}],"eventvisibility":"Public","amountvisibility":null,"fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJDkzryrCww","date":"Dec 2017","amount":"Undisclosed","source":"Rasham, https://www.linkedin.com/in/aviv-sagi-a138b15b/details/experience/","eventtype":"FundingRoundEvent","investment":[{"name":"M Ventures","type":"Investor","amount":0,"hidden":false,"country":"Netherlands","fullurl":"/investor_page/ms-ventures-israel-bioincubator","logokey":"$T9rrER6ccOAeHaUhrRclT8sLHnVVdbnxSAW33L0YVjduN9k2EI95Nh","tagline":null,"urlname":"/investor_page/ms-ventures-israel-bioincubator","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgL-llZsJDA","fundingtype":"Corporate VC","leadpartner":null,"investmentid":"6975c2b8-010d-43bb-a0ae-252d84deab5d","fundingsubtype":"Corporate VC","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$T9rrER6ccOAeHaUhrRclT8sLHnVVdbnxSAW33L0YVjduN9k2EI95Nh","leadcaption":"","followupcaption":""},{"name":"ExploreBio","type":"Investor","amount":0,"hidden":false,"country":"Germany","fullurl":"/investor_page/explorebio","logokey":"$xeJDSvrpZA4ZvZJyrZkazIiY2yQ9oTXuk9hljNhIbUa74sdwJXjlCg","tagline":null,"urlname":"/investor_page/explorebio","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoNm2u_ELDA","fundingtype":"Corporate VC","leadpartner":null,"investmentid":"7fb12cd4-e3b0-451f-aa4d-311c80fd32f1","fundingsubtype":"Corporate VC","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$xeJDSvrpZA4ZvZJyrZkazIiY2yQ9oTXuk9hljNhIbUa74sdwJXjlCg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"12/2017","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Immunorizon","logourl":"https://storage.googleapis.com/clean-finder-353810/$ssQcjPiSvqcUmSFyHChKIXzGUZooTfyoYf4viTyllGpoYwnGo5WQhq","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$ssQcjPiSvqcUmSFyHChKIXzGUZooTfyoYf4viTyllGpoYwnGo5WQhq","seoabout":"Immunorizon is developing conditionally activated tumor-restricted T- and NK-cell engagers for cancer therapy. The company extends its pipeline and uses tr...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":2,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drugs Discovery & Development","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":2,"name":"Cells","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7vMIDA","classificationName":"coretechnology"}],"classificationDelimited":["TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA>Cells#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7vMIDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA>Drugs Discovery & Development#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA"],"classificationsViewModel":"|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA|2:>TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA/Cells#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7vMIDA|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA/Drugs Discovery & Development#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Pharma & Medical Biotechnology","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology","children":[{"title":"Drugs Discovery & Development","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology>Drugs Discovery & Development"}]}]}],"targetCustomer":[],"coreTechnology":[{"title":"Biologicals","key":"0-0","path":"TechnologyClassificationModel>Biologicals","children":[{"title":"Cells","key":"0-0-0","path":"TechnologyClassificationModel>Biologicals>Cells"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drugs Discovery & Development","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":2,"name":"Cells","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7vMIDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[],"classificationNames":{"sector":["Health Tech & Life Sciences","Pharma & Medical Biotechnology","Drugs Discovery & Development"],"coreTechnology":["Biologicals","Cells"],"targetCustomer":[]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[{"id":"ZRQcERKz5pC08ibM3xtBBN3Jxs6tpU6MWyYrn3y206erEu5b4ljakV","date":"Feb 2023","amount":"$100M","source":"https://www.fiercebiotech.com/biotech/purple-biotech-paint-immunorizons-tri-specific-antibodies-100m-acquisition","mnatype":"Acquisition","eventtype":"MNAEvent","investment":[],"wasacquired":1,"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"acquiredcompany_mna":"Purple Biotech","acquiredcompany_mna_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6HiewIDA","acquiredcompany_mna_type":"Startup","acquiredcompany_mna_hidden":false,"acquiredcompany_mna_fullurl":"/company_page/kitov-pharmaceuticals","acquiredcompany_mna_logokey":"$25bRhdsVgwjsw5gGHwllY1Bhuh47gHfhNqXV6cabjGJHh5Ao4rQ1Dw","acquiredcompany_mna_urlname":"/company_page/kitov-pharmaceuticals","acquiredcompany_mna_homepage":"https://purple-biotech.com/","style":"","hiddenCompanyTooltip":"","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$25bRhdsVgwjsw5gGHwllY1Bhuh47gHfhNqXV6cabjGJHh5Ao4rQ1Dw","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","exit_label":"EXIT","po_label":"Initial Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":100000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"privateequityfunding":[{"id":"ISiyLn6zvM4pQ7W2pqGZxMzy69eMtrdLg2JlT7voCgiHLQghhxiCnO","date":"Feb 2020","amount":"Undisclosed","source":"m ventures","eventtype":"FundingRoundEvent","investment":[{"name":"M Ventures","type":"Investor","amount":null,"hidden":false,"country":"Netherlands","fullurl":"/investor_page/ms-ventures-israel-bioincubator","logokey":"$T9rrER6ccOAeHaUhrRclT8sLHnVVdbnxSAW33L0YVjduN9k2EI95Nh","tagline":null,"urlname":"/investor_page/ms-ventures-israel-bioincubator","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgL-llZsJDA","fundingtype":"Corporate VC","leadpartner":null,"investmentid":"4OAMXA0VJCdQwPTAAd930bKbC66sl1kynfu9QqWfPOIaI1fmBghQP7","fundingsubtype":"Corporate VC","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$T9rrER6ccOAeHaUhrRclT8sLHnVVdbnxSAW33L0YVjduN9k2EI95Nh","leadcaption":"","followupcaption":"Follow on "}],"eventvisibility":"Public","amountvisibility":null,"fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"CZDX5geGEMqhQjepWeHStWti2BKFDicKaq6FvOVLivMVnBbO8V7jqr","date":"Apr 2019","amount":"Undisclosed","source":"m ventures","eventtype":"FundingRoundEvent","investment":[{"name":"M Ventures","type":"Investor","amount":null,"hidden":false,"country":"Netherlands","fullurl":"/investor_page/ms-ventures-israel-bioincubator","logokey":"$T9rrER6ccOAeHaUhrRclT8sLHnVVdbnxSAW33L0YVjduN9k2EI95Nh","tagline":null,"urlname":"/investor_page/ms-ventures-israel-bioincubator","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgL-llZsJDA","fundingtype":"Corporate VC","leadpartner":null,"investmentid":"TbVtBlb53asL6frW31uPYgHRVM08OjvXEtnPBthvVTiAVZXM7Tcc8r","fundingsubtype":"Corporate VC","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$T9rrER6ccOAeHaUhrRclT8sLHnVVdbnxSAW33L0YVjduN9k2EI95Nh","leadcaption":"","followupcaption":"Follow on "}],"eventvisibility":"Public","amountvisibility":null,"fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJDkzryrCww","date":"Dec 2017","amount":"Undisclosed","source":"Rasham, https://www.linkedin.com/in/aviv-sagi-a138b15b/details/experience/","eventtype":"FundingRoundEvent","investment":[{"name":"M Ventures","type":"Investor","amount":0,"hidden":false,"country":"Netherlands","fullurl":"/investor_page/ms-ventures-israel-bioincubator","logokey":"$T9rrER6ccOAeHaUhrRclT8sLHnVVdbnxSAW33L0YVjduN9k2EI95Nh","tagline":null,"urlname":"/investor_page/ms-ventures-israel-bioincubator","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgL-llZsJDA","fundingtype":"Corporate VC","leadpartner":null,"investmentid":"6975c2b8-010d-43bb-a0ae-252d84deab5d","fundingsubtype":"Corporate VC","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$T9rrER6ccOAeHaUhrRclT8sLHnVVdbnxSAW33L0YVjduN9k2EI95Nh","leadcaption":"","followupcaption":""},{"name":"ExploreBio","type":"Investor","amount":0,"hidden":false,"country":"Germany","fullurl":"/investor_page/explorebio","logokey":"$xeJDSvrpZA4ZvZJyrZkazIiY2yQ9oTXuk9hljNhIbUa74sdwJXjlCg","tagline":null,"urlname":"/investor_page/explorebio","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoNm2u_ELDA","fundingtype":"Corporate VC","leadpartner":null,"investmentid":"7fb12cd4-e3b0-451f-aa4d-311c80fd32f1","fundingsubtype":"Corporate VC","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$xeJDSvrpZA4ZvZJyrZkazIiY2yQ9oTXuk9hljNhIbUa74sdwJXjlCg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}